19:39 IST
BSE
Other Announcement
Piramal Pharma Other Announcement
Piramal Pharma Limited informed exchanges that Niche99 has independently assigned it an ESG rating of 67.1 (ESG Band: Leader), without any company engagement.
Piramal Pharma Ltd
- Share price
- ₹203.01
- Market cap
- ₹27,028 Cr
- Revenue (annual)
- ₹8,869 Cr
- Net profit (annual)
- ₹-325.9 Cr
- P/E (TTM)
- -86.2×Sector 47.3×
- Promoter holding
- 34.80%-0.06% QoQ
- FII holding
- 12.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 3Business Update 3Share Pledge 2Merger & Restructuring 2Results Update 1Regulatory Approval 1Financial Results 1Employee Stock Options 1Earnings Call 1Board Meeting Date 1Annual General Meeting 1Adverse Business Impact 1
Time
3 announcements with these filters
14:28 IST
BSE
Other Announcement
Piramal Pharma Other Announcement
Piramal Pharma Limited received an improved ESG rating of 65 from NSE Sustainability Ratings and Analytics. The rating was assigned voluntarily based on public disclosures.
18:03 IST
BSE
Other Announcement
Piramal Pharma Other Announcement
Piramal Pharma Ltd has submitted its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI regulations.